The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Hull City midfielder Ryan Mason has been able to speak of the incident during the Chelsea match which saw him taken to hospital.
Theresa May was briefed on the Trident missile test which reportedly went wrong in June, it emerged this morning.
Christian Burgess joined an Under 12s side for training after Pompey's League Two game against Crawley Town was called off on Saturday.